From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology

Most treatments and diagnostics once took years and hundreds of millions of dollars. Today, it costs less than $100,000 to sequence a genome and open the door to tailored cancer therapies that could save lives. But understanding tumor biology is only half the battle. The real challenge lies in interpreting complex genetic data quickly, accurately, and at scale.

In this episode of AVBCC’s Value-Based Voices, James Hamrick, MD, MPH, Chair, Precision Oncology Alliance at Caris Life Sciences, teams up with John Fox, MD, MHA, Senior Medical Director for the Americas, Illumina, to explore how AI-driven bioinformatics is making genomic insights accessible and actionable. They reveal concrete strategies to overcome systemic hurdles such as inconsistent testing, reimbursement issues, and integrating insights into busy clinical workflows, that currently hinder widespread, equitable adoption of precision medicine.

Discover:

• How rapid DNA and RNA sequencing is transforming tumor profiling
• The critical role of bioinformatics and AI in interpreting complex genomes for real-world use
• Why comprehensive multi-omic panels and gene signatures are changing treatments and clinical trials
• The systemic, policy, and reimbursement barriers slowing progress, and what can be done to break them down
• How timely, precise testing can reduce costs, improve survival, and personalize treatment

This isn’t just about technology, it's about unlocking a new era of value-based, patient-centered cancer care that can save lives and resources. 

Resources & Links:

• Illumina
• National Comprehensive Cancer Network (NCCN)
• Caris Life Sciences
• Connect with Dr. James Hamrick:
• LinkedIn
•  Connect with Dr. John Fox:
• LinkedIn

Contact Value-Based Voices

- Follow AVBCC on LinkedIn  

- View our podcast lineup 

- Contact us at info@avbcc.org

Thanks for listening!